Michael Andrew Holloway Receives Stock Award at Lixte Biotechnology Holdings Inc (LIXT) — SEC Form 4, Jul 02, 2026

SEC Form 4 · No Market Transaction

Stock Award

Compensation grant — no market purchase or sale.

Reporting Owner

Michael Andrew Holloway

Director

TXN 2026-07-01 · FILED 2026-07-02

Equity Position 40K sh 25,000 → 40,000

Equity Change +60.0% shares held after vs before

Filing Lag 1 business day within 2-day SEC deadline

Form 4 · Statement of Changes in Beneficial Ownership

Lixte Biotechnology Holdings Inc

LIXT CIK 0001335105

Reporting Owner

Name	Relationship
Michael Andrew Holloway CIK 0002076371	Director

Michael Andrew Holloway at Lixte Biotechnology Holdings Inc Full insider history

Bought (12 mo) —

Sold (12 mo) —

More from this insider at Lixte Biotechnology Holdings Inc

2026-04-17	Award	—	View
2025-08-18	Award	—	View

Non-Derivative Securities Transactions

Title	Date	Type	Shares	Price	Net Total	Post-Txn	Ownership
Common StockF1 F2	2026-07-01	A - Award/Grant	15,000 A	$0.00	—	40,000	Direct

Footnotes (2)

F1: The reported transaction involved the Reporting Person's receipt of 15,000 restricted share units ("RSUs"). The RSUs were granted pursuant to the applicable RSU agreement and the Lixte Biotechnology Holdings, Inc. 2020 Stock Incentive Plan. Each RSU represents a contingent right to receive one share of common stock upon vesting, subject to continued service. The 15,000 RSUs vested upon the achievement of the performance conditions set forth in the Reporting Person's RSU agreement, which have been satisfied. Show more
F2: The total reported in Column 5 includes (i) the 15,000 newly awarded RSUs, and (ii) 25,000 RSUs, all of which have vested. Show more

Institutional Holders

Largest by reported value

5%+ Holders · 13D/G 4 filers

Latest Schedule 13D/G per filer; stakes the filer reported closed are left out.

Other insiders at Lixte Biotechnology Holdings Inc

GET /v1/forms/4/0001493152-26-031885 API docs